Compare AUPH & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUPH | DCO |
|---|---|---|
| Founded | 1993 | 1849 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 1999 | N/A |
| Metric | AUPH | DCO |
|---|---|---|
| Price | $15.20 | $96.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $17.25 | ★ $117.80 |
| AVG Volume (30 Days) | ★ 1.1M | 94.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | $265,808,000.00 | ★ $806,224,000.00 |
| Revenue This Year | $21.76 | $6.11 |
| Revenue Next Year | $16.45 | $8.03 |
| P/E Ratio | $28.99 | ★ N/A |
| Revenue Growth | ★ 20.62 | 3.17 |
| 52 Week Low | $6.55 | $51.76 |
| 52 Week High | $16.54 | $101.47 |
| Indicator | AUPH | DCO |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 57.12 |
| Support Level | $15.64 | $94.00 |
| Resistance Level | $15.98 | $99.23 |
| Average True Range (ATR) | 0.39 | 2.48 |
| MACD | -0.13 | 0.14 |
| Stochastic Oscillator | 13.73 | 59.52 |
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.